(Q33219578)

24 July 2017

title

Intravitreal triamcinolone for diffuse diabetic macular oedema (English)

1 reference

24 July 2017

Gibran SK

1

1 reference

24 July 2017

Cullinane A

series ordinal

2

1 reference

24 July 2017

Jungkim S

series ordinal

3

1 reference

24 July 2017

Cleary PE

series ordinal

4

1 reference

24 July 2017

publication date

8 July 2005

1 reference

24 July 2017

1 reference

24 July 2017

volume

20

1 reference

24 July 2017

issue

6

1 reference

24 July 2017

page(s)

720-724

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.eye.6701992

24 July 2017

exact match

0 references

cites work

Modified grid laser photocoagulation for diffuse diabetic macular edema. Long-term visual results

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701992

Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701992

Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701992

Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701992

Topography of diabetic macular edema with optical coherence tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701992

Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701992

Intravitreal triamcinolone for refractory diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701992

Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701992

Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701992

Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701992

Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701992

Intraocular pressure after intravitreal injection of triamcinolone acetonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701992

Acute endophthalmitis following intravitreal triamcinolone acetonide injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701992

Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701992

21 January 2018

Identifiers

DOI

10.1038/SJ.EYE.6701992

1 reference

Dimensions Publication ID

24 July 2017

1004064522

0 references

1 reference